VENLAFAXINE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Venlafaxine Market, By Indication (Major Depressive Disorder, Anxiety Disorder, Panic Disorder, Obsessive-Compulsive Disorder, Post-Traumatic Stress Disorder, Other Psychiatric Disorders), By Type (Generic, and Branded), By Dosage Form and Strength (Immediate-Release Tablets (25 mg, 37.5 mg, 50 mg, 75 mg, 100 mg), Extended-Release Capsules (37.5 mg, Extended-Release Tablets, and Oral Solution), By Age Group (Adults (18–64 years), and Geriatric Population (65 years and above)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By End User (Hospitals, Psychiatric Clinics, Homecare Settings, Long-Term Care Facilities, Rehabilitation Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In: 11 Mar, 2026
Code: CMI8191
Page number: 168
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Global Venlafaxine Market, By Indication
  - Global Venlafaxine Market, By Type
  - Global Venlafaxine Market, By Dosage Form and Strength
  - Global Venlafaxine Market, By Age Group
  - Global Venlafaxine Market, By Distribution Channel
  - Global Venlafaxine Market, By End User
  - Global Venlafaxine Market, By Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- Industry Trends
Global Venlafaxine Market, By Indication, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Major Depressive Disorder
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Anxiety Disorder
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Panic Disorder
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Obsessive-Compulsive Disorder
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Post-Traumatic Stress Disorder
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Psychiatric Disorders
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Venlafaxine Market, By Type, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Generic
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Branded
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Venlafaxine Market, By Dosage Form and Strength, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Immediate-Release Tablets
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    - 25 mg
    - 5 mg
    - 50 mg
    - 75 mg
    - 100 mg
- Extended-Release Capsules
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    - 5 mg
    - 75 mg
    - 150 mg
    - 225 mg
- Extended-Release Tablets
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Oral Solution
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    - 75mg/ml
    - 5 mg/mL
Global Venlafaxine Market, By Age Group, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Adults (18–64 years)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Geriatric Population (65 years and above)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Venlafaxine Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Venlafaxine Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hospitals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Psychiatric Clinics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Homecare Settings
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Long-Term Care Facilities
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Rehabilitation Centers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Venlafaxine Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
  - Market Share (%) Analysis, 2026,2028 & 2033, Value (USD Bn)
  - Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Dosage Form and Strength, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Dosage Form and Strength, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Dosage Form and Strength, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Dosage Form and Strength, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Dosage Form and Strength, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Dosage Form and Strength, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Mylan N.V.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Hetero Labs Limited
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Aurobindo Pharma
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Sun Pharmaceutical Industries
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Amgen Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Lupin Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Torrent Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Cadila Healthcare
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Glenmark Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Natco Pharma
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Reddy's Laboratories
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Alvogen
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Sandoz (a Novartis division)
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

*Browse 32 market data tables and 28 figures on ‘Venlafaxine Market' - Global forecast to 2033

Instant Download - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now